<p>苏文制药已更名为 Cohance Lifesciences，此变更在获得印度公司事务部批准后生效，具体信息在周三向印度证券交易所的文件中披露。</p>
<p>公司将向印度证券交易所，即孟买证券交易所和印度国家证券交易所申请，适时进行公司名称的变更。</p>
<p>该公司股票在最近的交易中下跌超过 1%。</p>

<p>苏文制药已更名为 Cohance Lifesciences，此变更在获得印度公司事务部批准后生效，具体信息在周三向印度证券交易所的文件中披露。公司将向印度证券交易所，即孟买证券交易所和印度国家证券交易所申请更改公司名称。该公司股票在最近的交易中下跌超过 1%</p>

<p>Suven Pharmaceuticals  has changed the company's name to Cohance Lifesciences with effect after receiving approval from India's Ministry of Corporate Affairs, according to a Wednesday filing to the Indian stock exchanges.</p>
<div class="lb-trans"><p>苏文制药已更名为 Cohance Lifesciences，此变更在获得印度公司事务部批准后生效，具体信息在周三向印度证券交易所的文件中披露。</p>
</div><p>The company will apply to the Indian stock exchanges, BSE and the National Stock Exchange of India, to effect the change of the company's name in due course.</p>
<div class="lb-trans"><p>公司将向印度证券交易所，即孟买证券交易所和印度国家证券交易所申请，适时进行公司名称的变更。</p>
</div><p>The company's shares were down over 1% in recent trade.</p>
<div class="lb-trans"><p>该公司股票在最近的交易中下跌超过 1%。</p>
</div>

苏文制药公司更名为 Cohance Lifesciences